Federico Giovagnorio

8PUBLICATIONS
44CO-AUTHORS
Major global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Infectious agentsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 28, 2026
Baseline Predictors of Adverse Outcome and Survival in Adults Hospitalized with Invasive Pneumococcal Disease.

|Jun 16, 2026
Eravacycline in sepsis complicated by Clostridioides difficile infection: a brief case series.

|Jul 28, 2025
Risk factors for 30-Day mortality and the role of empirical therapy in Pseudomonas aeruginosa bloodstream infections.

Nicholas Geremia, Federico Giovagnorio, Antonio Vena

|Mar 28, 2025
Rare or Unusual Non-Fermenting Gram-Negative Bacteria: Therapeutic Approach and Antibiotic Treatment Options.

Nicholas Geremia, Andrea Marino, Andrea De Vito

|Mar 27, 2025
Quantifying Gamma-Interferon from CMV-Specific CD8+ T Cells Defines Protection Against Clinically Significant CMV Infection in Solid Organ Transplant Recipients: The Quanti-CMV Score.

Elisa Ruiz-Arabi, Juan José Castón, Aurora Páez-Vega

|Jan 08, 2025
Fluoroquinolones and Biofilm: A Narrative Review.

Nicholas Geremia, Federico Giovagnorio, Agnese Colpani

Pageof 2

Frequent Collaborators

5 joint publications

Nicholas Geremia

4 joint publications

Andrea De Vito

4 joint publications

Giordano Madeddu

3 joint publications

Agnese Colpani